We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.
- Authors
Rashidi, Armin; Kaiser, Thomas; Graiziger, Carolyn; Holtan, Shernan G.; Rehman, Tauseef Ur; Weisdorf, Daniel J.; Dunny, Gary M.; Khoruts, Alexander; Staley, Christopher
- Abstract
<bold>Background: </bold>In the field of malignant hematology, most microbiome studies have focused on recipients of allogeneic hematopoietic cell transplantation (allo-HCT). As a result, this population has remained the primary target for novel microbiota therapeutics. Because the types of insults to the microbiome are similar during hematopoietic cell transplantation and intensive antileukemia therapy, this study evaluated whether the dysbiosis states are similar in the 2 settings.<bold>Methods: </bold>This study compared gut microbiota assemblages and community domination states in 2 cohorts of patients: patients with intensively treated acute leukemia (AL) and allo-HCT recipients. 16S ribosomal RNA gene profiling of thrice weekly stool samples was performed. Linear discriminant analysis effect size was used to determine differentially abundant taxa in groups of interest, and mixed modes were used to determine the predictors of microbiome states.<bold>Results: </bold>Microbiome changes in both cohorts were characterized by a marked loss of diversity and domination of low-diversity communities by Enterococcus. In the AL cohort, the relative abundance of Lactobacillus was also inversely correlated with diversity. Communities dominated by these genera were compositionally different.<bold>Conclusions: </bold>Similarities in microbiota assemblages between the 2 cohorts support a broader scope for microbiota-directed therapeutics than previously considered, whereas specific differences suggest a personalized aspect to such therapeutics with the possibility of a differential response.
- Subjects
CELL transplantation; PARAINFLUENZA viruses; FISHER discriminant analysis; ENTEROCOCCUS; ACUTE leukemia; RIBOSOMAL RNA; GUT microbiome; LEUKEMIA treatment; ANTINEOPLASTIC agents; COMPARATIVE studies; DEGENERATION (Pathology); HEMATOPOIETIC stem cell transplantation; RESEARCH methodology; MEDICAL cooperation; RESEARCH; EVALUATION research
- Publication
Cancer (0008543X), 2020, Vol 126, Issue 7, p1434
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/cncr.32641